TABLE 3.
Rate Ratios For Initiator Trials Versus Non-Initiator Trials at 10, 26, and 52 Weeks of Follow-up
| Outcome | Duration of Follow-up | Unadjusted Rate Ratios (95% CI) | Adjusted Rate Ratiosa (95% CI) |
|---|---|---|---|
| Initiator versus Non-Initiator Trials | |||
| Clinical remission | 26 wk | 1.44 (1.17–1.77) | 1.53 (1.20–1.96) |
| 52 wk | 1.46 (1.22–1.74) | 1.52 (1.23–1.89) | |
| Corticosteroid-free remission | 26 wk | 1.73 (1.38–2.16) | 1.74 (1.33–2.29) |
| 52 wk | 1.63 (1.35–1.97) | 1.62 (1.28–2.04) | |
a
Rate ratios were adjusted for patient age, gender, and race, disease location, duration, and phenotype, and concurrent medications, all measured at baseline of the trial.